Vyleesi 80064-0141-02
Generic: Bremelanotide
- Manufacturer
- Palatin Technologies
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 21, 2019
- Application
- NDA210557
Need to source Vyleesi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bremelanotide Acetate | 1.75 mg/.3mL |
Drug Class
Melanocortin Receptor Agonist [EPC]Melanocortin Receptor Agonists [MoA]
Selected Package
80064-0141-02Selected2 SYRINGE in 1 CARTON (80064-141-02) / .3 mL in 1 SYRINGE (80064-141-01)
Other packages for this product(1)
4 SYRINGE in 1 CARTON (80064-141-04) / .3 mL in 1 SYRINGE (80064-141-01)